Arechar Healthcare introduces the launch of Sunicine. Sunitinib tablet is standard care for the treatment of kidney and liver cancer and it helps to stop and slow down the growth of cancerous cells. It includes all receptors for a platelet-derived growth factor (PDGF-Rs) and vascular endothelial growth factor receptors (VEGFRs), which play a role in both tumor angiogenesis and tumor cell proliferation and help to shrink the tumor. The manufacturing unit of Arechar Healthcare has provided key features of Sunicine.
